Mutations in the SLC6A1 gene, which encodes GAT1, have been associated with a wide range of neurodevelopmental disorders, such as autism, intellectual disability, and epilepsy syndromes (Fischer et al., 2022). Here, SLC6A1 is linked to epilepsy syndrome.